Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER…

U.S. Department Of Veterans Affairs·Maryland

CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER RESEARCH

Closes 6/26/2026$200k – $500kRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Washington DC VA Medical Center (DC VAMC) is conducting a longitudinal study enrolling Veterans with metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). The study requires protein analysis services to support cancer research. The contractor will be responsible for conducting protein analysis on serial peripheral blood specimens collected at predefined timepoints before, during, and after treatment. Key aspects of the job include: • Conducting protein analysis on blood specimens • Supporting cancer research at the DC VAMC • Working with the DC VAMC research team to achieve study goals • Ensuring compliance with all applicable laws and regulations, including the Service Contract Act

Attached files

Contact

Veronica B. Dillard

[email protected]

Key dates

Opened
6/11/2026
Closes
6/26/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
36C24526Q0565

Budget estimate

$200,000 – $500,000

The estimated budget for this contract is difficult to determine without more information on the scope of work and the number of specimens to be analyzed. However, based on the complexity of the protein analysis services required, a rough estimate for the total contract value could be in the range of $200,000 to $500,000. This estimate is based on the assumption that the contractor will need to provide specialized equipment and personnel to conduct the protein analysis, and that the contract will be for a period of one to two years.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·Maryland

Top match · 72%

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

71% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. Department Of Energy·Ohio

70% match

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

70% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

70% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

University of Massachusetts·Massachusetts

69% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. National Institutes of Health·United States of America

69% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

69% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

Massachusetts Department of Public Health·Massachusetts

69% match

RFR 257030 Certified Oncology Data Specialist

Closes 6/30/2030Opened 3/6/2025

University of Texas MD Anderson Cancer Center·Texas

69% match

Discovery and Development of Small Molecules and Biologic Therapies RFP

Closes 12/9/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

69% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

Massachusetts Department of Public Health·Massachusetts

68% match

RFR 233132 Specialized Laboratory Testing Services

Closes 6/29/2032Opened 3/22/2022

U.S. Department Of Defense·United States of America

68% match

Non-Optical Methods for High Speed Protein Control

Closes 12/31/2026Opened 7/21/2026

U.S. National Institutes of Health·United States of America

68% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Department Of Veterans Affairs·Virginia

68% match

6640--JESS SIMPLE WESTERN AUTOMATED SYSTEM

Closes 11/3/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·Maryland

68% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·Georgia

68% match

CDC Technical Assistance for Program Implementation, Messaging, Evaluation, and Translation Services in Support of Nutrition, Physical Activity, and Obesity Prevention

Closes 11/10/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

68% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

Iowa State University·Iowa

68% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

68% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

68% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. Food and Drug Administration·United States of America

68% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

Massachusetts Department of Public Health·Massachusetts

67% match

RFR 224330 Anatomic Pathology Laboratory Services

Closes 9/1/2030Opened 8/18/2021